Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INSIGHT - The Impact of baseliNe viSual Acuity on the Treatment Outcomes in Patients Treated With AflIbercept in Real-life Clinical settinG. Analysis of Data From the SwedisH Macula RegisTer

NCT03278262 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT03278262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03278262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INSIGHT - The Impact of baseliNe viSual Acuity on the Treatment Outcomes in Patients Treated With AflIbercept in Real-life Clinical settinG. Analysis of Data From the SwedisH Macula RegisTer
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
September 1, 2017
Completion date
December 31, 2017
Enrollment
2,312 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

wet macular degeneration